Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 10, 2023
Discovery & Translation

Shinobi’s immune-protected cell therapies; plus Emugen, AZ and more

BioCentury’s roundup of translational innovations
BioCentury | Jan 29, 2019
Distillery Techniques

Biomarkers

BioCentury | Jul 25, 2017
Distillery Therapeutics

Cancer

BioCentury | Jun 2, 2016
Product R&D

Local reagent makes good

Genisphere turns old reagents into new nanoparticles, avoids liver
BioCentury | Mar 31, 2016
Distillery Therapeutics

Therapeutics: Elav like RNA binding protein 1 (ELAVL1)

Items per page:
1 - 5 of 5